How it went for everyone who tried it
Helped means they said it helped with what they took it for, which may be one symptom and not the illness.
Shares are out of the 9 people who said how it went. 2 more tried it without saying how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 1 | 11% |
| Helped | 3 | 34% |
| No change | 4 | 44% |
| Worse | 0 | 0% |
| Much worse | 1 | 11% |
| Where it was reported | Helped | Said how it went |
|---|---|---|
| 4 | 8 | |
| Recovery stories | 0 | 1 |
Did it last, for everyone it helped?
- None of the 4 people it helped said it wore off, whether or not they credit it for their improvement.
How it went for everyone who tried it
Helped means they said it helped with what they took it for, which may be one symptom and not the illness.
Shares are out of the 3 people who said how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 0 | 0% |
| Helped | 1 | 33% |
| No change | 2 | 67% |
| Worse | 0 | 0% |
| Much worse | 0 | 0% |
How it went for everyone who tried it
Helped means they said it helped with what they took it for, which may be one symptom and not the illness.
Shares are out of the 6 people who said how it went. 2 more tried it without saying how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 1 | 17% |
| Helped | 2 | 33% |
| No change | 2 | 33% |
| Worse | 0 | 0% |
| Much worse | 1 | 17% |
| Where it was reported | Helped | Said how it went |
|---|---|---|
| 3 | 5 | |
| Recovery stories | 0 | 1 |
Did it last, for everyone it helped?
- None of the 3 people it helped said it wore off, whether or not they credit it for their improvement.
Ask about this treatment
Among the 3 who credit it with their improvement, here’s how they are now
Credit it means they say it’s one reason they got better: 1 says it helped them most; 2 say it was one of several things that helped.
Where each person was at the end of their story, or in their latest post that says how they are, compared with their worst point.
| Outcome described | People | Share |
|---|---|---|
| Recovered | 0 | 0% |
| Near normal | 0 | 0% |
| Much better | 0 | 0% |
| Somewhat better | 3 | 100% |
| Relapsed | 0 | 0% |
Did it last?
- No one said its benefit wore off.
- 2 of the 3 who credit it say they still need to keep doing something (not always this) to stay well.
The one person who credits it with their improvement: here’s how they are now
Credit it means they say it’s one reason they got better: 1 says it was one of several things that helped.
Where each person was at the end of their story, or in their latest post that says how they are, compared with their worst point.
| Outcome described | People | Share |
|---|---|---|
| Recovered | 0 | 0% |
| Near normal | 0 | 0% |
| Much better | 0 | 0% |
| Somewhat better | 1 | 100% |
| Relapsed | 0 | 0% |
Did it last?
- No one said its benefit wore off.
- 1 of 1 who credits it says they still need to keep doing something (not always this) to stay well.
Among the 2 who credit it with their improvement, here’s how they are now
Credit it means they say it’s one reason they got better: 1 says it helped them most; 1 says it was one of several things that helped.
Where each person was at the end of their story, or in their latest post that says how they are, compared with their worst point.
| Outcome described | People | Share |
|---|---|---|
| Recovered | 0 | 0% |
| Near normal | 0 | 0% |
| Much better | 0 | 0% |
| Somewhat better | 2 | 100% |
| Relapsed | 0 | 0% |
Did it last?
- No one said its benefit wore off.
- 1 of the 2 who credit it says they still need to keep doing something (not always this) to stay well.
Everyone · not split by condition
By how ill people were
Only the 3 who credit it, so people it didn’t help or made worse aren’t here. How they are now is their outcome overall, not the effect of this one treatment.
| Severity at worst | How they are now | n | Recovered or near normal |
|---|---|---|---|
| Mild | 1 | 0%, few people | |
| Moderate | 1 | 0%, few people | |
| Severe | 1 | 0%, few people |
| At worst | Outcome | People | Share |
|---|---|---|---|
| Mild | Somewhat better | 1 of 1 | 100% |
| Moderate | Somewhat better | 1 of 1 | 100% |
| Severe | Somewhat better | 1 of 1 | 100% |
Everyone · not split by condition
What people started next
5 of the 9 people who said how it went saw no change or got worse. 3 of those 5 say what they started next.
Everyone · not split by condition
Adverse events
What people said went wrong, in their own words.
3 of 11
people who wrote about taking it described a problem they tied to it
The serious kinds
Worth telling a doctor about straight away.
Made them much worse
1 person“I'm on dose 2 of Dara at the moment. It's been extremely taxing on me so far.”
— Grove 65183 Blood count problems
1 person“My NK cells dropped to 90 and igg from 1200 > 800 after dose 1.”
— Grove 65183
The serious kinds are a death, suicidal thoughts or an attempt, a hospital stay, an ER visit, an allergic reaction or anaphylaxis, heart rhythm, liver or kidney, blood count, mood or psychiatric, or refeeding or deficiency problems, and being made much worse: a large worsening such as a crash lasting weeks or more.
Other kinds
Unpleasant effects people tied to it, the most serious first.
Made symptoms worse · 2Side effects · 1 Show all 2Hide
Made symptoms worse
2 people“Daratumumab took me from severe to extremely severe”
— Grove 65183 “None of them did a thing. If anything, they made me worse.”
— Hill 89598 Side effects
1 person“It gave her the expected side effects”
— dankeen's friend (unnamed)
All posts · not split by condition
How often it comes up
Posts that mention Daratumumab (Darzalex), per 1,000 posts each month. Hover or tap a point for the count.
| Month | Posts mentioning it | All posts | Per 1,000 |
|---|---|---|---|
| Oct 2009 | 0 | 105 | 0 |
| Jan 2010 | 0 | 141 | 0 |
| Feb 2010 | 0 | 113 | 0 |
| Jun 2011 | 0 | 109 | 0 |
| Nov 2011 | 0 | 124 | 0 |
| Dec 2011 | 0 | 199 | 0 |
| Jan 2012 | 0 | 232 | 0 |
| Feb 2012 | 0 | 103 | 0 |
| Mar 2012 | 0 | 190 | 0 |
| Apr 2012 | 0 | 162 | 0 |
| May 2012 | 0 | 375 | 0 |
| Jun 2012 | 0 | 238 | 0 |
| Jul 2012 | 0 | 240 | 0 |
| Aug 2012 | 0 | 485 | 0 |
| Sep 2012 | 0 | 561 | 0 |
| Oct 2012 | 0 | 526 | 0 |
| Nov 2012 | 0 | 514 | 0 |
| Dec 2012 | 0 | 699 | 0 |
| Jan 2013 | 0 | 533 | 0 |
| Feb 2013 | 0 | 447 | 0 |
| Mar 2013 | 0 | 429 | 0 |
| Apr 2013 | 0 | 499 | 0 |
| May 2013 | 0 | 606 | 0 |
| Jun 2013 | 0 | 609 | 0 |
| Jul 2013 | 0 | 616 | 0 |
| Aug 2013 | 0 | 577 | 0 |
| Sep 2013 | 0 | 364 | 0 |
| Oct 2013 | 0 | 536 | 0 |
| Nov 2013 | 0 | 385 | 0 |
| Dec 2013 | 0 | 519 | 0 |
| Jan 2014 | 0 | 944 | 0 |
| Feb 2014 | 0 | 821 | 0 |
| Mar 2014 | 0 | 425 | 0 |
| Apr 2014 | 0 | 361 | 0 |
| May 2014 | 0 | 617 | 0 |
| Jun 2014 | 0 | 489 | 0 |
| Jul 2014 | 0 | 444 | 0 |
| Aug 2014 | 0 | 622 | 0 |
| Sep 2014 | 0 | 507 | 0 |
| Oct 2014 | 0 | 678 | 0 |
| Nov 2014 | 0 | 567 | 0 |
| Dec 2014 | 0 | 629 | 0 |
| Jan 2015 | 0 | 760 | 0 |
| Feb 2015 | 0 | 873 | 0 |
| Mar 2015 | 0 | 1,276 | 0 |
| Apr 2015 | 0 | 984 | 0 |
| May 2015 | 0 | 1,496 | 0 |
| Jun 2015 | 0 | 1,046 | 0 |
| Jul 2015 | 0 | 1,211 | 0 |
| Aug 2015 | 0 | 998 | 0 |
| Sep 2015 | 0 | 1,060 | 0 |
| Oct 2015 | 0 | 1,255 | 0 |
| Nov 2015 | 0 | 1,246 | 0 |
| Dec 2015 | 0 | 924 | 0 |
| Jan 2016 | 0 | 1,282 | 0 |
| Feb 2016 | 0 | 1,051 | 0 |
| Mar 2016 | 0 | 1,002 | 0 |
| Apr 2016 | 0 | 998 | 0 |
| May 2016 | 0 | 1,045 | 0 |
| Jun 2016 | 0 | 1,230 | 0 |
| Jul 2016 | 0 | 1,619 | 0 |
| Aug 2016 | 0 | 1,729 | 0 |
| Sep 2016 | 0 | 1,785 | 0 |
| Oct 2016 | 0 | 1,220 | 0 |
| Nov 2016 | 0 | 1,092 | 0 |
| Dec 2016 | 0 | 1,211 | 0 |
| Jan 2017 | 0 | 1,660 | 0 |
| Feb 2017 | 0 | 1,988 | 0 |
| Mar 2017 | 0 | 2,078 | 0 |
| Apr 2017 | 0 | 2,133 | 0 |
| May 2017 | 0 | 2,370 | 0 |
| Jun 2017 | 0 | 2,194 | 0 |
| Jul 2017 | 0 | 2,183 | 0 |
| Aug 2017 | 0 | 2,466 | 0 |
| Sep 2017 | 0 | 2,189 | 0 |
| Oct 2017 | 0 | 3,042 | 0 |
| Nov 2017 | 0 | 1,976 | 0 |
| Dec 2017 | 0 | 2,112 | 0 |
| Jan 2018 | 0 | 2,620 | 0 |
| Feb 2018 | 0 | 2,155 | 0 |
| Mar 2018 | 0 | 2,613 | 0 |
| Apr 2018 | 0 | 2,251 | 0 |
| May 2018 | 0 | 2,828 | 0 |
| Jun 2018 | 0 | 3,871 | 0 |
| Jul 2018 | 0 | 3,067 | 0 |
| Aug 2018 | 0 | 3,757 | 0 |
| Sep 2018 | 0 | 3,512 | 0 |
| Oct 2018 | 0 | 3,261 | 0 |
| Nov 2018 | 0 | 2,861 | 0 |
| Dec 2018 | 0 | 2,754 | 0 |
| Jan 2019 | 0 | 3,672 | 0 |
| Feb 2019 | 0 | 2,715 | 0 |
| Mar 2019 | 0 | 3,317 | 0 |
| Apr 2019 | 0 | 3,141 | 0 |
| May 2019 | 0 | 3,855 | 0 |
| Jun 2019 | 0 | 3,392 | 0 |
| Jul 2019 | 0 | 3,312 | 0 |
| Aug 2019 | 0 | 3,943 | 0 |
| Sep 2019 | 0 | 4,035 | 0 |
| Oct 2019 | 0 | 3,922 | 0 |
| Nov 2019 | 0 | 3,508 | 0 |
| Dec 2019 | 0 | 3,659 | 0 |
| Jan 2020 | 0 | 4,650 | 0 |
| Feb 2020 | 0 | 4,374 | 0 |
| Mar 2020 | 0 | 4,475 | 0 |
| Apr 2020 | 0 | 3,690 | 0 |
| May 2020 | 0 | 4,543 | 0 |
| Jun 2020 | 0 | 5,701 | 0 |
| Jul 2020 | 0 | 6,104 | 0 |
| Aug 2020 | 0 | 10,333 | 0 |
| Sep 2020 | 0 | 11,958 | 0 |
| Oct 2020 | 0 | 14,568 | 0 |
| Nov 2020 | 0 | 16,546 | 0 |
| Dec 2020 | 0 | 20,764 | 0 |
| Jan 2021 | 0 | 24,562 | 0 |
| Feb 2021 | 0 | 24,672 | 0 |
| Mar 2021 | 0 | 29,476 | 0 |
| Apr 2021 | 0 | 28,509 | 0 |
| May 2021 | 0 | 25,791 | 0 |
| Jun 2021 | 0 | 27,871 | 0 |
| Jul 2021 | 0 | 27,220 | 0 |
| Aug 2021 | 0 | 30,808 | 0 |
| Sep 2021 | 0 | 30,074 | 0 |
| Oct 2021 | 0 | 22,132 | 0 |
| Nov 2021 | 0 | 27,722 | 0 |
| Dec 2021 | 0 | 31,872 | 0 |
| Jan 2022 | 0 | 42,317 | 0 |
| Feb 2022 | 0 | 38,697 | 0 |
| Mar 2022 | 0 | 44,305 | 0 |
| Apr 2022 | 0 | 44,333 | 0 |
| May 2022 | 0 | 50,594 | 0 |
| Jun 2022 | 0 | 49,058 | 0 |
| Jul 2022 | 0 | 53,485 | 0 |
| Aug 2022 | 0 | 54,455 | 0 |
| Sep 2022 | 0 | 56,936 | 0 |
| Oct 2022 | 0 | 58,511 | 0 |
| Nov 2022 | 0 | 59,198 | 0 |
| Dec 2022 | 0 | 61,576 | 0 |
| Jan 2023 | 0 | 61,004 | 0 |
| Feb 2023 | 0 | 50,133 | 0 |
| Mar 2023 | 1 | 59,925 | 0.02 |
| Apr 2023 | 0 | 54,251 | 0 |
| May 2023 | 1 | 57,768 | 0.02 |
| Jun 2023 | 2 | 52,679 | 0.04 |
| Jul 2023 | 1 | 56,401 | 0.02 |
| Aug 2023 | 1 | 65,435 | 0.02 |
| Sep 2023 | 1 | 61,835 | 0.02 |
| Oct 2023 | 2 | 58,419 | 0.03 |
| Nov 2023 | 3 | 53,662 | 0.06 |
| Dec 2023 | 6 | 60,643 | 0.10 |
| Jan 2024 | 2 | 71,818 | 0.03 |
| Feb 2024 | 2 | 70,045 | 0.03 |
| Mar 2024 | 0 | 68,261 | 0 |
| Apr 2024 | 1 | 64,374 | 0.02 |
| May 2024 | 1 | 67,698 | 0.01 |
| Jun 2024 | 0 | 64,720 | 0 |
| Jul 2024 | 0 | 65,335 | 0 |
| Aug 2024 | 1 | 68,517 | 0.01 |
| Sep 2024 | 0 | 70,168 | 0 |
| Oct 2024 | 2 | 72,607 | 0.03 |
| Nov 2024 | 9 | 71,802 | 0.13 |
| Dec 2024 | 6 | 74,401 | 0.08 |
| Jan 2025 | 1 | 77,909 | 0.01 |
| Feb 2025 | 1 | 65,110 | 0.02 |
| Mar 2025 | 1 | 69,905 | 0.01 |
| Apr 2025 | 6 | 61,606 | 0.10 |
| May 2025 | 47 | 65,733 | 0.72 |
| Jun 2025 | 35 | 60,540 | 0.58 |
| Jul 2025 | 29 | 62,105 | 0.47 |
| Aug 2025 | 32 | 64,578 | 0.50 |
| Sep 2025 | 54 | 61,704 | 0.88 |
| Oct 2025 | 25 | 59,204 | 0.42 |
| Nov 2025 | 29 | 58,944 | 0.49 |
| Dec 2025 | 40 | 62,830 | 0.64 |
| Jan 2026 | 22 | 63,321 | 0.35 |
| Feb 2026 | 17 | 53,085 | 0.32 |
| Mar 2026 | 26 | 59,208 | 0.44 |
| Apr 2026 | 25 | 53,989 | 0.46 |
| May 2026 | 23 | 57,541 | 0.40 |
| Jun 2026 | 20 | 55,301 | 0.36 |
| Jul 2026 | 13 | 56,391 | 0.23 |
| Aug 2026 | 18 | 56,825 | 0.32 |
| Sep 2026 | 13 | 57,143 | 0.23 |
Forum and Reddit posts, 4,007,898 in all, counted per month. A mention means the post names the treatment, not that the writer took it. All trends
All 11 people who tried it
-
Mild ME/CFS with extreme fatigue and brain fog, now somewhat better on LDN and modafinil
A Singapore user developed mild ME/CFS overnight in early 2025, a week after a COVID infection; extreme fatigue, brain fog and muscle weakness persisted. LDN, LDA, keto and other interventions cleared most side symptoms such as joint pain, twitching and…
-
Long COVID with severe fatigue and brain fog, somewhat better on daratumumab
Sequoia 23892 has had long COVID for several years, with severe fatigue, brain fog, knee and back pain and orthostatic intolerance. Baricitinib, taken about 18 months, cleared their knee pain within weeks, and fludrocortisone worked better than midodrine for…
-
At 25% functioning with ME/CFS, somewhat better after daratumumab
A person with PEM, Sjögren's, small fibre neuropathy and dysautonomia was at about 25% functioning before four daratumumab (Darzalex) injections in March 2025. They credited the drug with a large improvement to roughly 40-45% functioning, though not…
-
ME/CFS, three daratumumab doses gave some symptom benefit, more may be needed
A person who had frozen their eggs in the hope of having children if they recovered bought daratumumab themselves at about €1,500 a dose. Three doses were very well tolerated but gave only some symptom benefit and nothing they called miraculous; they thought…
-
Ill six years with ME/CFS, in bed all day from surges; another treatment did nothing
Ill for six years, the person developed seizure-like adrenergic surges — a burning panic-like sensation spreading through brain, limbs, stomach and lungs — that start on waking and keep them in bed all day. A treatment tried a couple of months before…
-
Fully bedbound with ME/CFS, no improvement; LDN and pyridostigmine helped sleep only
Grove 65183, a 37-year-old New Jersey teacher, fell ill with long COVID in February 2024, two months after a mild infection, with severe neurological and dysautonomic symptoms. Acute symptoms settled but fatigue, weakness, PEM and POTS persisted and he…
-
Housebound with ME/CFS, improved, then relapsed to bedbound
Fell ill in March 2019 at 22 with vertigo, orthostatic intolerance and constant anxiety; housebound for a month. Propranolol, duloxetine and ivabradine let them walk up to an hour and work online by 2022; betahistine later helped vertigo and brain fog. In…
-
Full-blown ME/CFS with PEM and POTS, now somewhat better on IVIG
After several mild COVID infections without lasting problems, this user pushed through a mild infection in September 2024 during a flat move instead of resting. About three months later PEM and POTS appeared, and by July 2025 they described full-blown…
-
Mostly bedbound with long COVID, partial gains then a relapse
A student who fell ill with COVID in March 2020, aged 16, never recovered, with brain fog, breathlessness and chest pain, later heat intolerance and anhedonia. By early 2024 they were mostly bedbound; whole-food vitamin C with tyrosine, a phlebotomy,…
-
Long COVID with nerve pain, low mood and brain fog; LDN, TMS and ketamine no benefit
Ill with long COVID for about five years, with nerve pain probably from small fibre neuropathy, low mood and brain fog. LDN from a supplier whose pills lab-tested as fake, TMS, ketamine infusions and Paxlovid gave no benefit; one treatment increased symptoms…
-
List of ME/CFS Recovery and Improvement Stories (page 13 discussion)
Her ME followed covid early in the pandemic and was of moderate severity, with part-time remote work done with difficulty. After daratumumab and bortezomib gave no symptom improvement, five IV cyclophosphamide doses from March 2024 were followed by…
The first 3 credit Daratumumab (Darzalex) for their improvement; the other 8 tried it without crediting it.
All 3 people who tried it
-
Long COVID with severe fatigue and brain fog, somewhat better on daratumumab
Sequoia 23892 has had long COVID for several years, with severe fatigue, brain fog, knee and back pain and orthostatic intolerance. Baricitinib, taken about 18 months, cleared their knee pain within weeks, and fludrocortisone worked better than midodrine for…
-
Mostly bedbound with long COVID, partial gains then a relapse
A student who fell ill with COVID in March 2020, aged 16, never recovered, with brain fog, breathlessness and chest pain, later heat intolerance and anhedonia. By early 2024 they were mostly bedbound; whole-food vitamin C with tyrosine, a phlebotomy,…
-
Long COVID with nerve pain, low mood and brain fog; LDN, TMS and ketamine no benefit
Ill with long COVID for about five years, with nerve pain probably from small fibre neuropathy, low mood and brain fog. LDN from a supplier whose pills lab-tested as fake, TMS, ketamine infusions and Paxlovid gave no benefit; one treatment increased symptoms…
The first one credits Daratumumab (Darzalex) for their improvement; the other 2 tried it without crediting it.
All 8 people who tried it
-
Mild ME/CFS with extreme fatigue and brain fog, now somewhat better on LDN and modafinil
A Singapore user developed mild ME/CFS overnight in early 2025, a week after a COVID infection; extreme fatigue, brain fog and muscle weakness persisted. LDN, LDA, keto and other interventions cleared most side symptoms such as joint pain, twitching and…
-
At 25% functioning with ME/CFS, somewhat better after daratumumab
A person with PEM, Sjögren's, small fibre neuropathy and dysautonomia was at about 25% functioning before four daratumumab (Darzalex) injections in March 2025. They credited the drug with a large improvement to roughly 40-45% functioning, though not…
-
ME/CFS, three daratumumab doses gave some symptom benefit, more may be needed
A person who had frozen their eggs in the hope of having children if they recovered bought daratumumab themselves at about €1,500 a dose. Three doses were very well tolerated but gave only some symptom benefit and nothing they called miraculous; they thought…
-
Ill six years with ME/CFS, in bed all day from surges; another treatment did nothing
Ill for six years, the person developed seizure-like adrenergic surges — a burning panic-like sensation spreading through brain, limbs, stomach and lungs — that start on waking and keep them in bed all day. A treatment tried a couple of months before…
-
Fully bedbound with ME/CFS, no improvement; LDN and pyridostigmine helped sleep only
Grove 65183, a 37-year-old New Jersey teacher, fell ill with long COVID in February 2024, two months after a mild infection, with severe neurological and dysautonomic symptoms. Acute symptoms settled but fatigue, weakness, PEM and POTS persisted and he…
-
Housebound with ME/CFS, improved, then relapsed to bedbound
Fell ill in March 2019 at 22 with vertigo, orthostatic intolerance and constant anxiety; housebound for a month. Propranolol, duloxetine and ivabradine let them walk up to an hour and work online by 2022; betahistine later helped vertigo and brain fog. In…
-
Full-blown ME/CFS with PEM and POTS, now somewhat better on IVIG
After several mild COVID infections without lasting problems, this user pushed through a mild infection in September 2024 during a flat move instead of resting. About three months later PEM and POTS appeared, and by July 2025 they described full-blown…
-
List of ME/CFS Recovery and Improvement Stories (page 13 discussion)
Her ME followed covid early in the pandemic and was of moderate severity, with part-time remote work done with difficulty. After daratumumab and bortezomib gave no symptom improvement, five IV cyclophosphamide doses from March 2024 were followed by…
The first 2 credit Daratumumab (Darzalex) for their improvement; the other 6 tried it without crediting it.